Lisa A. Carmody

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations”.

Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations

Annals of the American Thoracic Society(2023)10.1513/annalsats.202306-576oc

N/A

0.703DataRank · unranked

20 citations

Lindsay J. Caverly, Linda M. Kalikin, Lisa A. Carmody, Scott McClellan, William LeBar +8 more

Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination

mSystems(2020)10.1128/msystems.00296-20

N/A

0DataRank · unranked

35 citations

Lisa A. Carmody, Kristopher Opron, Richard H. Simon, Linda M. Kalikin, Lindsay J. Caverly +2 more

Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways

The ISME Journal(2021)10.1038/s41396-021-01129-z

N/A

0DataRank · unranked

43 citations

Jiangchao Zhao, Lisa A. Carmody, Qingyang Zhang, Linda M. Kalikin, Patrick D. Schloss +2 more

Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.05.011

N/A

0DataRank · unranked

12 citations

Linda M. Kalikin, Donald R. VanDevanter, Gen Li, Kristopher Opron, Richard H. Simon +3 more

Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.05.011

N/A

0DataRank · unranked

11 citations

Amalia Magaret, Lisa A. Carmody, Linda M. Kalikin, Richard H. Simon, John J. LiPuma +2 more

Airway bacterial community composition in persons with advanced cystic fibrosis lung disease

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.01.001

N/A

0DataRank · unranked

8 citations

Lisa A. Carmody, Linda M. Kalikin, Kristopher Opron, Lindsay J. Caverly, John J. LiPuma +1 more

Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.21.550012

N/A

0DataRank · unranked

0 citations

Kristopher Opron, Lisa A. Carmody, Linda M. Kalikin, Lindsay J. Caverly, John J. LiPuma +1 more

Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.11.013

N/A

0DataRank · unranked

2 citations

Lindsay J. Caverly, Linda M. Kalikin, Christina S. Thornton, Richard H. Simon, Donald R. VanDevanter +2 more

Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00927-20

N/A

0DataRank · unranked

15 citations

Stefan Riedel, Joseph Kapcia, Lindsay J. Caverly, Lisa A. Carmody, Linda M. Kalikin +10 more

Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis

Research Square(2024)10.21203/rs.3.rs-4128740/v1

N/A

0DataRank · unranked

0 citations

Lisa A. Carmody, Kristopher Opron, Linda M. Kalikin, Lindsay J. Caverly, John J. LiPuma +1 more